Skip to content

CorMedix CRMD Current ratio

Current ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Merck & Co. logo
Merck & Co.MRK
1.3×-0.1×
Merit Medical Systems logo
Merit Medical SystemsMMSI
5.1×+0.2×
ITG
Integer HoldingsITGR
3.8×+0.4×
IAR
Integra LifeSciencesIART
3.4×+2.2×
MiMedx Group logo
MiMedx GroupMDXG
5.4×+0.7×

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on the most recent quarter.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's current ratio?
CorMedix (CRMD) reported current ratio of 3× in Q1 2026.
How has CorMedix's current ratio changed year-over-year?
CorMedix's current ratio decreased by 29.4% year-over-year, from 4.2× to 3×.
What is the long-term trend for CorMedix's current ratio?
Over 5 years (2020 to 2025), CorMedix's current ratio has grown at a -28.9% compound annual growth rate (CAGR), from 11.6× to 2.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.